DK1711052T3 - Musemodel for psoriasis og psoriatisk arthrit - Google Patents

Musemodel for psoriasis og psoriatisk arthrit

Info

Publication number
DK1711052T3
DK1711052T3 DK05706932.0T DK05706932T DK1711052T3 DK 1711052 T3 DK1711052 T3 DK 1711052T3 DK 05706932 T DK05706932 T DK 05706932T DK 1711052 T3 DK1711052 T3 DK 1711052T3
Authority
DK
Denmark
Prior art keywords
psoriasis
mouse model
psoriatic arthritis
junb
epidermis
Prior art date
Application number
DK05706932.0T
Other languages
English (en)
Inventor
Erwin Wagner
Rainer Zenz
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK1711052T3 publication Critical patent/DK1711052T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knockout animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A01K2217/203—Animal model comprising inducible/conditional expression system, e.g. hormones, tet
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A01K2217/206—Animal model comprising tissue-specific expression system, e.g. tissue specific expression of transgene, of Cre recombinase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0325—Animal model for autoimmune diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/02—Cells from transgenic animals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
DK05706932.0T 2004-01-21 2005-01-20 Musemodel for psoriasis og psoriatisk arthrit DK1711052T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04001181A EP1557085A1 (en) 2004-01-21 2004-01-21 Mouse model for human psoriasis
PCT/EP2005/000517 WO2005070199A1 (en) 2004-01-21 2005-01-20 Mouse model for psoriasis and psoriatic arthritis

Publications (1)

Publication Number Publication Date
DK1711052T3 true DK1711052T3 (da) 2012-08-20

Family

ID=34626473

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05706932.0T DK1711052T3 (da) 2004-01-21 2005-01-20 Musemodel for psoriasis og psoriatisk arthrit

Country Status (7)

Country Link
EP (2) EP1557085A1 (da)
JP (1) JP4778446B2 (da)
AT (1) ATE556588T1 (da)
CA (1) CA2552756C (da)
DK (1) DK1711052T3 (da)
ES (1) ES2386287T3 (da)
WO (1) WO2005070199A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090307784A1 (en) * 2005-10-21 2009-12-10 Medical Research Council Methods of Analysing Cell Behaviour
KR101263622B1 (ko) * 2008-02-21 2013-05-10 고쿠리쓰다이가쿠호진 에히메다이가쿠 고혈압 감수성 유전자군의 동정
CN101570739B (zh) * 2009-06-05 2012-10-03 刘晓明 银屑病基础研究模型的建立方法及气液平面跨膜装置
ES2352929B1 (es) * 2009-08-14 2012-01-26 Centro De Investigaciones Energeticas. Medioamb Ientales Y Tecnologicas (Ciemat) Modelo humanizado de psoriasis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU698317B2 (en) * 1995-02-25 1998-10-29 Cancer Research Technology Limited Transgenic animals as model of psoriasis
CZ20003842A3 (cs) 1998-04-17 2001-08-15 Société des Produits Nestlé S. A. Buněčná linie lidských keratinocytů
EP1055366A1 (en) * 1999-05-26 2000-11-29 Boehringer Ingelheim International GmbH Use of transgenic mice lacking jun-b expression in the myeloid lineage
DE10011926A1 (de) * 2000-01-14 2001-08-02 Deutsches Krebsforsch Genetisch veränderte Fibroblastenzellen
AU2002251429B2 (en) * 2001-02-09 2007-01-18 Torbjorn Egelrud SCCE modified transgenic mammals and their use as models of human disease

Also Published As

Publication number Publication date
WO2005070199A1 (en) 2005-08-04
EP1711052B1 (en) 2012-05-09
CA2552756C (en) 2013-08-06
EP1557085A1 (en) 2005-07-27
JP2007518413A (ja) 2007-07-12
ES2386287T3 (es) 2012-08-16
CA2552756A1 (en) 2005-08-04
EP1711052A1 (en) 2006-10-18
ATE556588T1 (de) 2012-05-15
JP4778446B2 (ja) 2011-09-21

Similar Documents

Publication Publication Date Title
CY2015018I2 (el) Ανθρωπινα αντισωματα ειδικα για kdr και χρησεις αυτων
ATE529161T1 (de) Tumorbehandlungs-identifikationssystem
DE602004018680D1 (de) Verfahren zur verringerung des exkrementgeruchs von heimtieren
ATE447393T1 (de) Kosmetische wasser-in-öl-emulsionen mit organischem sonnenschutz und konjugierter linolsäure
DE502006003622D1 (de) Kletterschalung mit angelenktem kletterschuh
DE60323875D1 (de) Eine atp-rückzykluslänge verwendende vorrichtung zur unterscheidung von arrythmien
ATE420432T1 (de) Verfahren und vorrichtung zur prädiktiven quantisierung von stimmhaften sprachsignalen
DE60223361D1 (de) Objektidentifikation
DK1711052T3 (da) Musemodel for psoriasis og psoriatisk arthrit
FR2852229B1 (fr) Prothese totale d'epaule.
ATE424724T1 (de) Verwendung von n-arylhydrazinderivaten für die bekämpfung von schädlingen in und an tieren
ATE464396T1 (de) Mikrosatellitenmarker in form von mononukleotidwiederholungen zur detektion von mikrosatelliteninstabilität
Walder The Nineteenth-Century Novel: Identities
Foreman et al. Improving recognition of delirium in the elderly
Povilitis What is a natural area?
BR0215897B1 (pt) prepreg e método para sua produção
ATE405288T1 (de) Selektion von eimeriastämmen in geflügel über extraintestinale sporozoiten
Waterman et al. Utilizing the national physical activity plan to create a disease-specific approach: environmental and policy strategies to increase physical activity among adults with arthritis
DK1280404T3 (da) Model for neurodegenerativ sygdom
Sukenti et al. Kajian Etnobotani Serat Centhini
Murphy The ethics of distance
Coggan et al. Landholders driving change: exploring new incentives. Scoping and trialling incentives and institutional arrangements
Narsey Expressive space: engaging the architectural experience between the tectonic and stereotomic
Murphy The enigma of distance
Perrin et al. Rhinoceros Hornbill Water Based Enrichment Device